Dupilumab (Dupixent) for severe eczema in infants
To find out safety and effectiveness of dupilumab (Dupixent) in infants with severe eczema.
To find out safety and effectiveness of dupilumab (Dupixent) in infants with severe eczema.
The aim of this project is to delineate androgen effects on regional adipose depots and ectopic fat non-invasively by magnetic resonance (MR)-based imaging techniques in youth with Congenital Adrenal Hyperplasia (CAH).
To find out the effects of ApoE4 on the Preterm Brain.
Validate the use of respiratory inductance plethysmography (RIP) and esophageal manometry in diagnosing upper airway obstruction (UAO) in newborn infants.
To better understand the genetic changes that make children susceptible to the development of autism spectrum disorder, and to study how these changes influence clinical outcomes.
Determine how potentially stressful situations, including prematurity, hospitalizations, maternal mental health and rapid repeat births can impact a baby’s development in the first 12 months of their life.
To investigate the connection between diet, genetics, and diseases in Hispanic / Latino youth.
1) To determine if 5 doses of Epo (Erythropoietin) 1000 U/kg (birth weight) intravenous (IV) reduces the rate of death or neurodevelopmental impairment (mild, moderate, or severe) at 24 months of age.
2) To assess safety of Epo.
3) To determine whether Epo decreases the severity of HIE-induced brain injury as evidenced by early MRI and plasma biomarkers of brain injury.
The purpose of this study is to understand the impact of the COVID-19 pandemic on vulnerable families in Los Angeles, including those caring for a child with special health care needs. Information from this research will be used to understand what the key resource and service needs of families are at this time as well as identify interventions that can be developed or adapted to address these needs.
We are interested in observing whether and how infants learn when interacting with a robot during a learning assessment contingency paradigm.